Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

Ageas, Agfa, D’Ieteren, Ion Beam: Benelux Equity Market Preview

Don't Miss Out —
Follow us on:

Oct. 4 (Bloomberg) -- The following companies may have unusual price changes in Benelux markets. Stock symbols are in parentheses, and prices are from the previous close.

The AEX-Index in Amsterdam declined 1.6 percent to 275.64. Belgium’s Bel20 Index lost 1.6 percent to 2,096.74. Luxembourg’s LuxX Index dropped 1 percent to 1,073.15.

Belgian stocks:

Ageas (AGS BB): The insurer formerly known as Fortis said Augur Capital AG agreed to buy its German life-insurance unit for an undisclosed amount. Ageas will record a “limited” loss on the transaction. The shares fell 3.1 percent to 1.27 euros.

Agfa-Gevaert NV (AGFB BB): Europe’s biggest maker of health-care imaging systems said it won a three-year extension of a contract with Novation to provide digital radiography products to the buying alliance’s 30,000 member organizations in the U.S. Agfa shares tumbled 7.1 percent to 1.82 euros.

D’Ieteren SA (DIE BB): Belgium’s biggest car dealer’s share of the country’s market widened to 24.3 percent in September as car registrations jumped 12 percent to 41,427, according to figures published by trade group Febiac. D’Ieteren climbed 1.8 percent to 38.20 euros.

Ion Beam Applications SA (IBAB BB): Europe’s largest maker of proton-therapy equipment said it won a contract with the Willis-Knighton Cancer Center in Shreveport, Louisiana, to install a Proteus ONE facility valued at $25 million to $30 million. Ion Beam retreated 0.6 percent to 5 euros.

To contact the reporter on this story: John Martens in Brussels at jmartens1@bloomberg.net

To contact the editor responsible for this story: Angela Cullen at acullen8@bloomberg.net;

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.